{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:57:24Z","timestamp":1769302644399,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00259-016-3351-3","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T04:38:58Z","timestamp":1457671138000},"page":"1646-1652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["18F-FDG PET\/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Verena","family":"Ruhlmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten Dirk","family":"Poeppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Sascha","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Gr\u00fcneisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Ruhlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Matthias","family":"Theysohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Forsting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Bockisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"3351_CR1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1148\/75.3.380","volume":"75","author":"J Dineen","year":"1960","unstructured":"Dineen J, Asch T, Pearce JM. Retroperitoneal fibrosis. An anatomic and radiologic review with a report of four new cases and an explanation of pathogenesis. Radiology. 1960;75:380\u201390.","journal-title":"Radiology"},{"key":"3351_CR2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1148\/rg.332125085","volume":"33","author":"RO Caiafa","year":"2013","unstructured":"Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN. Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics. 2013;33:535\u201352.","journal-title":"Radiographics"},{"key":"3351_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"367","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367:241\u201351.","journal-title":"Lancet"},{"key":"3351_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1440-1673.2006.01654.x","volume":"51","author":"T Geoghegan","year":"2007","unstructured":"Geoghegan T, Byrne AT, Benfayed W, McAuley G, Torreggiani WC. Imaging and intervention of retroperitoneal fibrosis. Australas Radiol. 2007;51:26\u201334.","journal-title":"Australas Radiol"},{"key":"3351_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2008-1027881","volume":"181","author":"M Heckmann","year":"2009","unstructured":"Heckmann M, Uder M, Kuefner MA, Heinrich MC. Ormond\u2019s disease or secondary retroperitoneal fibrosis? An overview of retroperitoneal fibrosis. Rofo. 2009;181:317\u201323.","journal-title":"Rofo"},{"key":"3351_CR6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00120-007-1504-5","volume":"46","author":"AS Brandt","year":"2007","unstructured":"Brandt AS, Soares SB, Fehr A, Kukuk S, Mathers MJ, St\u00f6rkel S, et al. \u201cRetroperitoneal fibrosis\u201d (RPF) urologic cooperation and research project. Urologe A. 2007;46:1302\u20134.","journal-title":"Urologe A"},{"key":"3351_CR7","first-page":"168","volume":"53","author":"PR Burn","year":"2002","unstructured":"Burn PR, Singh S, Barbar S, Boustead G, King CM. Role of gadolinium-enhanced magnetic resonance imaging in retroperitoneal fibrosis. Can Assoc Radiol J. 2002;53:168\u201370.","journal-title":"Can Assoc Radiol J"},{"key":"3351_CR8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0031-1273450","volume":"183","author":"L Kamper","year":"2011","unstructured":"Kamper L, Brandt AS, Scharw\u00e4chter C, Kukuk S, Roth S, Haage P, et al. MR evaluation of retroperitoneal fibrosis. Rofo. 2011;183:721\u20136.","journal-title":"Rofo"},{"key":"3351_CR9","first-page":"49","volume":"5","author":"AS Brandt","year":"2013","unstructured":"Brandt AS, Kamper L, Kukuk S, Piroth W, Haage P, Roth S. An aid to decision-making in therapy of retroperitoneal fibrosis: dynamic enhancement analysis of gadolinium MRI. J Clin Med Res. 2013;5:49\u201356.","journal-title":"J Clin Med Res"},{"key":"3351_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5152\/dir.2014.14027","volume":"20","author":"L Kamper","year":"2014","unstructured":"Kamper L, Brandt AS, Ekamp H, Abanador-Kamper N, Piroth W, Roth S, et al. Diffusion-weighted MRI findings of treated and untreated retroperitoneal fibrosis. Diagn Interv Radiol. 2014;20:459\u201363.","journal-title":"Diagn Interv Radiol"},{"key":"3351_CR11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","volume":"21","author":"I Jansen","year":"2010","unstructured":"Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2010;21:216\u201321.","journal-title":"Eur J Intern Med"},{"key":"3351_CR12","first-page":"338","volume":"31","author":"S Yilmaz","year":"2012","unstructured":"Yilmaz S, Tan YZ, Ozhan M, Halac M, Asa S, et al. FDG PET\/CT in monitoring treatment of retroperitoneal fibrosis. Rev Esp Med Nucl Imagen Mol. 2012;31:338\u20139.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"3351_CR13","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","volume":"39","author":"G Moroni","year":"2012","unstructured":"Moroni G, Castellani M, Balzani A, Dore R, Bonelli N, Longhi S, et al. The value of (18)F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging. 2012;39:1635\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3351_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11604-012-0066-7","volume":"30","author":"F Bertagna","year":"2012","unstructured":"Bertagna F, Treglia G, Leccisotti L, Bosio G, Motta F, Giordano A, et al. [18F]FDG-PET\/CT in patients affected by retroperitoneal fibrosis: a bicentric experience. Jpn J Radiol. 2012;30:415\u201321.","journal-title":"Jpn J Radiol"},{"key":"3351_CR15","first-page":"231","volume":"23","author":"A Vaglio","year":"2005","unstructured":"Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent \u201cscar\u201d? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol. 2005;23:231\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"3351_CR16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12149-010-0341-6","volume":"24","author":"S Washino","year":"2010","unstructured":"Washino S, Hirai M, Matsuzaki A, Kobayashi Y. (18)F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis. Ann Nucl Med. 2010;24:225\u20139.","journal-title":"Ann Nucl Med"},{"key":"3351_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12149-007-0077-0","volume":"22","author":"PM Young","year":"2008","unstructured":"Young PM, Peterson JJ, Calamia KT. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18FDG PET: report of three cases. Ann Nucl Med. 2008;22:87\u201392.","journal-title":"Ann Nucl Med"},{"key":"3351_CR18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2967\/jnumed.108.054726","volume":"50","author":"A Martinez-M\u00f6ller","year":"2009","unstructured":"Martinez-M\u00f6ller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd\u2019hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET\/MRI: evaluation with PET\/CT data. J Nucl Med. 2009;50:520\u20136.","journal-title":"J Nucl Med"},{"key":"3351_CR19","first-page":"293","volume":"5","author":"J Bini","year":"2015","unstructured":"Bini J, Robson PM, Calcagno C, Eldib M, Fayad ZA. Quantitative carotid PET\/MR imaging: clinical evaluation of MR-attenuation correction versus CT-attenuation correction in (18)F-FDG PET\/MR emission data and comparison to PET\/CT. Am J Nucl Med Mol Imaging. 2015;5:293\u2013304.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"3351_CR20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-015-3145-z","volume":"43","author":"BM Schaarschmidt","year":"2016","unstructured":"Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, et al. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET\/CT and integrated PET\/MRI. Eur J Nucl Med Mol Imaging. 2016;43:92\u2013102.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3351_CR21","doi-asserted-by":"publisher","unstructured":"Salkind NJ, editor. Encyclopedia of measurements and statistics. Thousand Oaks: SAGE; 2007. doi: 10.4135\/9781412952644 .","DOI":"10.4135\/9781412952644"},{"key":"3351_CR22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/RLU.0b013e3182478bd3","volume":"37","author":"R Guignard","year":"2012","unstructured":"Guignard R, Simukoniene M, Garibotto V, Ratib O. 18F-FDG PET\/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis? Clin Nucl Med. 2012;37:453\u20139.","journal-title":"Clin Nucl Med"},{"key":"3351_CR23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1259\/bjr.73.866.10884739","volume":"73","author":"I Vivas","year":"2000","unstructured":"Vivas I, Nicol\u00e1s AI, Vel\u00e1zquez P, Elduayen B, Fern\u00e1ndez-Villa T, Mart\u00ednez-Cuesta A. Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol. 2000;73:214\u201322.","journal-title":"Br J Radiol"},{"key":"3351_CR24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00259-013-2580-y","volume":"41","author":"A Varoquaux","year":"2014","unstructured":"Varoquaux A, Rager O, Poncet A, Delattre BM, Ratib O, Becker CD, et al. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET\/MR versus PET\/CT. Eur J Nucl Med Mol Imaging. 2014;41:462\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3351_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/art.20914","volume":"53","author":"A Vaglio","year":"2005","unstructured":"Vaglio A, Versari A, Fraternali A, Ferrozzi F, Salvarani C, Buzio C. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and follow up of idiopathic retroperitoneal fibrosis. Arthritis Rheum. 2005;53:122\u20135.","journal-title":"Arthritis Rheum"},{"key":"3351_CR26","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/ndt\/gfq051","volume":"25","author":"GB Piccoli","year":"2010","unstructured":"Piccoli GB, Consiglio V, Arena V, Pelosi E, Anastasios D, Ragni F, et al. Positron emission tomography as a tool for the \u201ctailored\u201d management of retroperitoneal fibrosis: a nephro-urological experience. Nephrol Dial Transplant. 2010;25:2603\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"3351_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10334-012-0359-y","volume":"26","author":"U Pietrzyk","year":"2013","unstructured":"Pietrzyk U, Herzog H. Does PET\/MR in human brain imaging provide optimal co-registration? A critical reflection. MAGMA. 2013;26:137\u201347.","journal-title":"MAGMA"},{"key":"3351_CR28","first-page":"608","volume":"46","author":"G Brix","year":"2005","unstructured":"Brix G, Lechel U, Glatting G, Ziegler SI, M\u00fcnzing W, M\u00fcller SP, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET\/CT examinations. J Nucl Med. 2005;46:608\u201313.","journal-title":"J Nucl Med"},{"key":"3351_CR29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.24461","volume":"61","author":"MN Magrey","year":"2009","unstructured":"Magrey MN, Husni ME, Kushner I, Calabrese LH. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum. 2009;61:674\u20139.","journal-title":"Arthritis Rheum"},{"key":"3351_CR30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ejrad.2013.01.008","volume":"82","author":"P Heusch","year":"2013","unstructured":"Heusch P, Buchbender C, Beiderwellen K, Nensa F, Hartung-Knemeyer V, Lauenstein TC, et al. Standardized uptake values for [18F]FDG in normal organ tissues: comparison of whole-body PET\/CT and PET\/MRI. Eur J Radiol. 2013;82:870\u20136.","journal-title":"Eur J Radiol"},{"key":"3351_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096751","volume":"9","author":"J Grueneisen","year":"2014","unstructured":"Grueneisen J, Beiderwellen K, Heusch P, Buderath P, Aktas B, Gratz M, et al. Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET\/MRI of primary and recurrent cervical cancer. PLoS One. 2014;9,e96751.","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1007\/s00259-016-3376-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000}}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3351-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3351-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:06:31Z","timestamp":1558713991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3351-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3351"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3351-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00259-016-3376-7","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]}}}